Skip to Content
Worthington & Caron, PC Worthington & Caron, PC
Top

OVER $2.5 BILLION

OBTAINED FOR MESOTHELIOMA PATIENTS & FAMILIES
Statin tablet
|

Statins May Increase Effectiveness in Immunotherapy Treatment for Mesothelioma

Statin tablet

A December 2020 study revealed that high doses of statins (lipid-lowering medications) have a synergistic effect on PD-1 immunotherapy treatments yielding better clinical outcomes for pleural mesothelioma and advanced non-small cell lung cancer patients.

The study involved statins taken in combination with Opdivo by patients receiving second or third-line treatment. The response rate was 22% for patients receiving Opdivo and statins vs. 6% for those not receiving statins. Progression-free survival was 6.7 months vs. 2.3 months respectively. A control group of patients who received statins with chemotherapy no increase in response or survival rates.

Our Mission

  • Medical Empowerment

    Get the information you need to make informed decisions about your treatment.

    Learn More
  • Legal Empowerment

    Get the compensation you need to address the financial cost of your illness.

    Learn More
  • Going For The Gold

    Helping empower our clients with over $2.5 Billion in recoveries. We fight for our clients!

    Settlements & Verdicts
  • Giving Back To The Community

    Unprecedented Support for Mesothelioma Research. See how we can help!

    Our Contributions

Get Empowered

We put your medical and personal needs first and provide compassionate representation.
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.
  • By submitting, you agree to be contacted about your request & other information using automated technology. Message frequency varies. Msg & data rates may apply. Text STOP to cancel. Acceptable Use Policy